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ABSTRACT 
Int J Exerc Sci 5(1) : 50-59, 2012. Caffeine is thought to provide ergogenic benefits during 
endurance performance. However, there is limited research on the effects of caffeine on anaerobic 
sports performance. The purpose of this study was to examine the effects of 6 mg·kg-1 of caffeine 
on repeated sprint performance. The sample included active college students (N = 18), classified 
as habitual caffeine or caffeine naïve users. Participants completed a 12 x 30-m sprint test with 35 
s rest intervals between sprints. Ratings of Perceived Exertion were collected every 3rd sprint. 
Height and body mass were measured and participants accommodated to the sprint test on Day 
1. Participants were randomly assigned to the placebo or caffeine condition on Day 2 and the 
treatment was reversed on Day 3. Caffeine was ingested in a sports drink 1 h prior to performing 
the sprints. Caffeine produced a significantly faster best sprint time compared to the placebo trial, 
F (1, 17) = 7.38, MSE = .02, H-F p = .02. However, no significant difference was found between 
caffeine supplementation and placebo on time to complete the total sprint test. Additionally, no 
significant difference was found in sprint times with caffeine supplementation by sex or between 
caffeine-naïve and habitual caffeine users. Finally, a significantly higher average RPE was found 
with caffeine supplementation as compared to the placebo, t (1, 17) = 2.92, d = .38, p = .01. 
Caffeine has the potential to enhance sprint performance however, further research with women 
and habitual caffeine consumers is needed. 
 
KEY WORDS:  Ergogenic aids, repeated sprint ability, anaerobic exercise, 
methylxanthines 
 
 
 
 
INTRODUCTION 
 
Caffeine is one of the most frequently 
consumed drugs in the world, and has 
minimal health risks (18). It is found in 
numerous foods including chocolate and 
beverages, with coffee, tea, and soft drinks 
being consumed most frequently (16). 
Caffeine is also found in some over-the-
counter medications and energy drinks.   
 
Caffeine is quickly absorbed with plasma 
levels reaching a maximum level within 1 h 
of ingestion (18). Caffeine is slowly 
catabolized with a half-life or time to 
decrease its initial quantity by one half, of 4 
to 6 h (18). Factors such as oral 
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contraceptive use and smoking may affect 
the half-life of caffeine (1, 7, 23). Caffeine is 
catabolized by the cytochrome P450 system 
in the liver to three dimethylxanthines: 
paraxanthine, theophylline, and 
theobromine, which are then further 
catabolized (18).  
  
The details of how caffeine provides 
ergogenic aid to sports performance remain 
unclear, although several explanations have 
been proposed. Costill and colleagues 
proposed an increased use of fat as fuel for 
exercise thus sparing liver and muscle 
glycogen (13). An increased reliance on 
lipolysis benefits performance by 
conserving liver and muscle glycogen 
leading to delayed muscle fatigue. 
However, this mechanism may only be 
beneficial for endurance sports because the 
oxidative energy system is not dominant 
during anaerobic activities such as 
sprinting. 
 
Another possible mechanism for caffeine’s 
ergogenic effect during exercise is its effect 
on the central nervous system (CNS).  
Because of caffeine’s lipid solubility, it is 
able to cross the blood-brain barrier (20) 
and act as an adenosine antagonist (14). The 
receptors that are most likely affected by 
caffeine are the A1 and A2A receptors (16). 
Caffeine’s ability to act as an adenosine 
blockade in the CNS appears to be the most 
promising mechanism of action. While the 
mechanism of how caffeine may provide 
ergogenic aid remains debatable, much 
research has been conducted to test 
caffeine’s effects during sports 
performance. 
 
With the World Anti-Doping Agency 
(WADA) removing caffeine from the 
banned substance list in 2004 (26) and the 
National Collegiate Athletic Association 
(NCAA) setting a high urinary level of 15 
g/mL for a positive test (21), the door has 
now been opened for further investigation 
on the effects of caffeine on sports 
performance. Since 1978, numerous 
researchers have investigated caffeine’s 
possible ergogenic effects on endurance 
capacity (4, 5, 6, 9, 13, 15). While many of 
the earlier studies provided mixed results, 
more recent studies clearly show that 
caffeine has the possibility to be ergogenic 
for both long-term and short-term 
endurance performance (4, 5, 6, 9, 13, 15), 
although the degree of its effects may 
depend on the characteristics of the users, 
such as level of training (12) and habitual 
use of caffeine (4).  
 
Researchers have also investigated the 
effect of caffeine on anaerobic performance. 
Collomp et al. (11), Greer et al. (19), and 
Bell et al. (3) all failed to show 
improvement from caffeine in a Wingate 
testing protocol. While Wingate testing is 
purported to be a test of anaerobic power, it 
may be impractical for sports that involve 
multiple bouts of high intensity work. 
Repeated sprints are found in numerous 
sports including track, American football, 
basketball, and soccer. Because these sports 
have maximal or near maximal sprints 
accompanied by brief periods of rest or low 
intensity running, caffeine may be 
beneficial in these sports due to the mixed 
aerobic and anaerobic components.  
 
Collomp et al. (12) found that specific 
training may be needed to see an effect 
from a 250 mg caffeine supplementation. 
These researchers concluded that intra- 
and/or extra-cellular adaptions that result 
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from specific training are necessary to 
benefit from caffeine during sprint 
performance. One potential issue with their 
study was the use of an absolute dosage of 
caffeine as opposed to a relative to body 
mass dosage. This may have provided 
smaller individuals with a greater effect 
and larger individuals with less of an effect 
from the caffeine.  
 
Both Stuart et al. (25) and Schneiker et al. 
(24) found improved performance from 
tests designed to mimic the demands of 
various sports. Both studies used 6 mg·kg-1 
of caffeine and found improvements in 
performance while caffeine levels remained 
below a positive drug test according to 
NCAA policy (24, 25). Glaister et al. (17) 
and Carr et al. (10) also found improved 
sprint performance from both 5 mg·kg-1 and 
6 mg·kg-1 of caffeine. Participants in both 
studies were active individuals however, 
the studies included only male participants. 
While there are relatively few studies to 
investigate caffeine supplementation in a 
repeated sprint testing protocol, the lack of 
female participants is a recurring theme (10, 
17, 22, 24, 25).   
 
Paton et al. (22) however, found caffeine 
supplementation to not be beneficial in 
team sport athletes. This study did include 
a relative to body mass dosage, however 
the testing protocol may not have allowed 
enough rest time between sprints. The 
testing protocol consisted of 10 sprints each 
of 20 m in distance. Each sprint was 
required to be performed in 10 s with the 
remainder of that time for rest.    
The ability to develop tolerance to caffeine 
effects is well known (16). There is an 
increase in the number of adenosine A1 
receptors following long-term caffeine use 
(16). Some researchers have attempted to 
address if differences exist in the 
effectiveness of a caffeine supplement on 
sports performance in those with habitual 
caffeine use compared to those consuming 
small amounts of caffeine. Dodd et al. (15) 
found no effect on VO2 max or anaerobic 
threshold from a caffeine supplement of 5 
mg·kg-1  in habitual and caffeine naïve 
participants. While resting metabolism and 
ventilation, as well as resting and exercise 
plasma free fatty acid (FFA) increased in 
the caffeine naïve group, this did not affect 
performance outcomes (15). However, Bell 
et al. (4) found that differences did exist 
between habitual and caffeine naïve users. 
Using a 5 mg·kg-1 body mass caffeine 
supplement and 6 exercise rides to 
exhaustion, the results indicated that the 
ergogenic effect was greater in nonusers, 
resulting in increased time to exhaustion. 
Controversy still exists if habitual use of 
caffeine will lead to decreased effectiveness 
of a caffeine supplement on sports 
performance.  
 
Therefore, the purpose of this study was to 
examine the effects of ingesting 6 mg·kg -1 
body mass of caffeine on performance in a 
multiple sprint running ability test with 
male and female participants who were 
either habitual caffeine consumers or 
caffeine naïve. It was hypothesized that 
caffeine ingestion would significantly 
decrease the time to complete the fastest 
individual sprint and total time to complete 
the repeated sprint protocol as compared to 
the fastest placebo trial and total time and 
that habitual caffeine users would see less 
improvement in fastest individual sprint 
times than caffeine naïve participants. 
Additionally, it was hypothesized that 
there would be no significant sex difference 
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in the effect of caffeine on sprint times 
(individual sprint times and total time to 
complete test procedure). Finally, it was 
hypothesized that average rating of 
perceived exertion (RPE) recorded during 
the repeated sprint testing protocol would 
be significantly lower in the caffeine trial as 
compared to the placebo trial. 
 
METHODS 
 
Participants 
The participants included 18 active college 
students from the southeastern United 
States who were classified as caffeine naïve 
(6 males, 4 females) or habitual caffeine 
users (3 males, 5 females) based on a 
questionnaire created by the principal 
investigator. Most of the participants in the 
study were undergraduate exercise science 
majors. Three of the participants were 
NCAA Division I collegiate athletes playing 
basketball (n = 1) or softball (n = 2). Most 
participants had a history of sports 
participation in a variety of sports. None of 
the participants were smokers and all of the 
female participants but two were taking 
oral contraception. Demographic 
characteristics are presented in Table 1. 
Participants gave their verbal and written 
informed consent to participate in the study 
that was approved by the University 
Institutional Review Board.   
 
Experimental design 
Volunteers for the study first completed 
questionnaires, without knowledge of the 
study purpose, to assess their 
qualifications. The first questionnaire 
included questions on age, sex, Attention 
Deficit Disorder/Attention Deficit 
Hyperactivity Disorder (ADD/ADHD), 
contraceptive usage for female participants, 
exercise habits (including the types of 
exercise and for how long they participated 
in these activities), smoking habits, and 
lastly, caffeine usage. An attempt to include 
all forms of caffeine was made on this 
questionnaire which included soft drinks, 
as well as other drinks including, but not 
limited to, coffee, foods such as chocolate 
candy bars, over-the-counter medication, 
and prescription medications. Participants 
were asked to report use of the products on 
an “average” day’s use.  
 
Table 1. Demographics for the Sample (N = 18) and 
Female (n = 9) and Male (n = 9) Participants 
 
Note. BMI = body mass index. 
 
The second questionnaire was the Physical 
Activity Readiness Questionnaire (PAR-Q). 
To qualify for participation, participants 
had to be active (defined as engaging in at 
least 3.5 h per week of exercise), a non-
smoker, caffeine naïve (defined as 
consuming less than 50 mg · day -1 or less) 
or habitual caffeine user (defined as 
consuming equal to or greater than 300 mg 
· day -1), not taking medication for 
ADD/ADHD, and finally have no health 
issues as determined by the PAR-Q. Terms 
to define habitual and caffeine naïve were 
similar to those previously defined by Bell 
et al. (4). Of the volunteers who met the 
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study requirements, 11 females (6 habitual 
caffeine users and 5 caffeine naïve) along 
with 11 males (5 habitual caffeine users and 
6 caffeine naïve) were selected to complete 
this study. 
 
During day 1, the participants’ height and 
body mass were recorded. Body mass (to 
the nearest 0.1 kg) was measured via a scale 
(SECA; Hanover, MD) with the participants 
dressed in shorts and a shirt and the 
caffeine dosage was calculated from this 
measurement. Height was measured with a 
stadiometer (SECA; Hanover, MD) to the 
nearest 0.1 cm. Participants were asked to 
remove their shoes for both measurements. 
Using height and body mass, the BMI of 
each participant was calculated. Day 1 was 
also used to familiarize the participants 
with the testing protocol. After day 1, 4 
participants (2 habitual caffeine males, 1 
habitual caffeine female, and 1 caffeine 
naïve female) decided to withdraw from 
the study due to scheduling conflicts with 
coaches or injury.   
 
Participants were given 3 days notice prior 
to days 2 and 3 and, consistent with 
previous literature (3, 6, 15), were asked to 
refrain from caffeine usage (all food, 
prescription medication, and beverages) 
and vigorous exercise 24 h prior to testing 
(3, 6, 15). This served as the washout period 
for previous caffeine usage to assure equal 
dosing. Participants were allowed to 
maintain their normal diet but were asked 
to avoid consumption of food or beverage 
(with the exception of the test drink) within 
1 h of testing. All testing occurred within a 
2 week time period with day 1 occurring 
during week 1 and experimental days 2 and 
3 occurring during week 2 with 48 h of rest 
between trials.  
 
Using a within-subjects experimental 
design, participants received either caffeine 
(6 mg·kg-1 body mass; Sigma Aldrich) 
mixed in a sports drink or a placebo (plain 
sports drink) 1 h prior to testing. All 
dosages were above all the participants’ 
normal caffeine consumption (caffeine 
naïve M =  27.66 mg, habitual caffeine M =  
314.80 mg). The treatment (caffeine or 
placebo) was distributed with participants 
blind to the condition (prescribed caffeine 
M = 425.57 mg). Assignment to the 
treatment condition was conducted in a 
randomized and counterbalanced manner. 
The treatment was reversed during day 3 
for each participant for the counterbalanced 
experimental design. During all testing 
sessions, RPE, Borg scale 6 – 20 (8), was 
collected from the participants’ every third 
sprint. Participants were equally 
encouraged and motivated to give their 
best effort before and throughout each 
testing session. Timing of the sprints was 
recorded electronically using a twin-beam 
photocell timing gate system (Brower 
Timing System; Draper, UT).  
 
Before testing began on days 2 and 3, 
participants completed a standard warm-
up consisting of 1 lap of jogging (self-
selected pace) around the University’s 
indoor track, ad libitum stretching, and a 1 
x 30 m sprint. Using a similar testing 
protocol to Glaister et al. (17), participants 
individually completed a repeated sprint 
test (12 x 30-m; repeated at 35 s intervals). 
Sprints were performed in opposite 
directions to maximize the 35 s recovery 
time between sprints. Participants were 
instructed to stand behind the starting line 
to prevent premature triggering of the 
timing gates and were given a verbal 5 s 
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countdown prior to each sprint. Each sprint 
began with the participants in an athletic 
stance with their non-dominant foot 
forward.  
 
Statistical analysis 
The Statistical Package for the Social 
Sciences for Windows (SPSS Inc., Chicago, 
IL, Version 17.0) was used for statistical 
analyses. A repeated-measure analysis of 
variance (RMANOVA) was utilized to test 
the differences in the fastest sprint times 
and total time to complete the sprint test 
between the caffeine and placebo trials. An 
independent t-test was utilized to test the 
difference between the sexes and between 
caffeine naïve and habitual caffeine use on 
sprint times and total time to complete the 
sprint test. A difference score was created 
by subtracting the caffeine trial from the 
placebo trial for both the total time and 
individual sprints. Finally, a paired t-test 
was used to analyze average RPE from the 
caffeine and placebo trials. Average RPE 
was calculated by averaging the RPE of 
sprints 3, 6, 9, and 12. Cohen’s d was used 
to calculate effect sizes. The method of 
Cohen’s d used was (M1 – M2/ pooled SD). 
Pooled SD was calculated with the formula 
[(SD1 + SD2)/2]. The statistical significance 
was set at an alpha level of .05 for all 
analyses. 
 
 
 
RESULTS 
 
There was a significant difference between 
caffeine supplementation and placebo on 
the fastest individual sprint time for the full 
sample F1, 17 = 7.38, MSE = .02, P = .02. 
However, no significant difference between 
caffeine supplementation and placebo was 
found on the time to complete the total 
sprint test for the full sample F1, 17 = 3.94, 
MSE = 1.47, P = .06. While all mean sprint 
times were faster with caffeine, only sprints 
3 and 5 reached the level of significance (see 
Table 2). Further, no significant sex 
difference was found in total time to 
complete the sprint test as well as 
individual sprint times with caffeine 
supplementation as compared to without 
caffeine supplementation (see Table 3). No 
significant difference was found between 
caffeine naïve (M = .08 s, SD = .14 s, n = 10) 
and habitual caffeine users (M = .17 s, SD = 
.24 s, n = 8) in the difference score of the 
fastest individual sprint times, t 1, 16 = -1.01, 
d = -.46, P = .33. Finally, a significantly 
higher average RPE was found with 
caffeine supplementation as compared to 
the placebo trial t 1, 17 = 2.92, d = .38, P = .01 
(See Table 2). 
 
Table 2. Sprint Times (s) and RPE for the Full 
Sample (N = 18) 
 
Note. Values presented as mean ± standard 
deviation; RPE = Rating of perceived exertion; * P < 
.05; ** P = .01 
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Table 3. Difference in Sprint Times (s) Caffeine 
Supplement vs. Placebo by Sex 
 
Note. Values presented as mean ± standard deviation 
 
DISCUSSION 
 
The purpose of this study was to test the 
effect of 6-mg·kg -1 body mass of caffeine on 
multiple sprint running performance in 
active male and female participants who 
were either habitual caffeine consumers or 
caffeine naïve. Glaister et al. (17) was the 
model for this study. However, this study 
included both male and female participants 
and also examined the effect of the 
supplement on habitual and caffeine naïve 
users.  
 
Caffeine ingestion produced a significant 
improvement in the fastest individual 
sprint as compared to the non-caffeine 
sprint trial. Consequently, the hypothesis 
that caffeine ingestion would significantly 
decrease the time to complete the fastest 
individual sprint was supported.  This 
finding supports the results of previous 
studies showing improved performance 
with caffeine supplementation (2, 3, 4, 5, 9, 
10, 12, 13, 17, 24, 25) and contrasts with 
other studies showing no improvement (11, 
15, 19, 22). However, while the mean times 
with caffeine were faster for all sprints, only 
sprints 3 and 5 reached statistical 
significance. The lack of statistical 
significance on all sprints may have been 
due to the small sample size. The mean 
sprint times and effect sizes all indicate a 
decrease with the caffeine supplement that 
may reach significance with a larger sample 
size. While only two sprints reached the 
level of significance, the practical results 
show that caffeine has the potential to 
improve sports performance with sports 
that include multiple sprints.  
 
No significant difference was found in the 
fastest individual sprint times with caffeine 
ingestion between caffeine naïve and 
habitual caffeine consuming participants. 
Therefore, the hypothesis that habitual 
caffeine consumers would see less of a 
reduction in the fastest individual sprint 
times with caffeine ingestion compared to 
caffeine naïve participants was not 
supported. The reason for the hypothesis 
that habitual caffeine users would see less 
of a benefit from caffeine was the 
physiological adaptations that occur with 
regular caffeine usage. It has been 
suggested that those who consume caffeine 
on a long-term basis build-up additional 
adenosine receptors (18) and therefore it 
may take more caffeine for the same effect 
in this group. The results of this study 
indicate that habitual caffeine usage 
potentially has no detrimental effect on 
caffeine’s ergogenic effect in a sprint test 
protocol.  
 
Similar terms were used to define caffeine 
usage in the current study and the study by 
Bell et al. (4) that also included male and 
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female participants. However, the finding 
in this study contradicts the finding of Bell 
et al. (4) who indicated nonusers received a 
greater benefit from caffeine 
supplementation. The key difference 
between the studies was the testing 
protocols with the present study being 
anaerobic in nature and that of Bell et al. (4) 
being an aerobic protocol. However, Dodd 
et al. (15) also found no significant 
difference between male habitual caffeine 
users and caffeine naïve users. These 
authors (15) defined caffeine usage in a 
similar manner to the present study.  
 
The change in performance in individual 
and total sprint times in response to 
caffeine was not different in males and 
females. Thus, the hypothesis that that 
there would be no significant sex difference 
in the effect of caffeine on sprint times 
(individual sprint times and total time to 
complete test procedure) was supported. 
While this study found no sex differences 
with the supplement, more research studies 
are needed comparing sexes.  
 
The average RPE for every third sprint was 
found to be significantly higher with 
caffeine than without caffeine. Therefore, 
the hypothesis that average rating of 
perceived exertion (RPE) recorded during 
the repeated sprint testing protocol would 
be significantly lower in the caffeine trial as 
compared to the placebo was not 
supported. This is an interesting finding 
because it is the opposite of traditional 
thought and previous research that 
indicates that caffeine lowers RPE (13). 
Glaister et al. (17), using the same testing 
protocol as this study, found no significant 
difference in RPE. In the study by Glaister 
et al. (17), which included measures of 
heart rate, the mean increase in heart rate 
was 3.4 bpm. A review article by 
Freedholm et al. (16) also indicated that 
high caffeine intake produces tachycardia. 
Glaister et al. (17) also reported increased 
blood lactate concentrations both pre-and 
post-testing with caffeine. Other studies 
have also reported increases in blood 
lactate levels with caffeine supplementation 
(2, 3, 10, 11). Although heart rate and lactate 
measures were not taken in this present 
study, if caffeine produced these same 
effects, this may be a reason for the 
increased RPE. Glaister et al. (17) also 
mentioned that increases in RPE 
corresponded with increases (decrement) in 
sprint time and heart rate, which indicates 
the validity of the RPE scale for a sprint 
testing protocol.  
 
It is also important to note that while RPE 
was statistically different between 
conditions, the difference may not be 
practically significant. Because RPE is 
reported as a whole number, both the 
average RPE with and without caffeine was 
13. This shows that while it was statistically 
significant, it was not different in a practical 
sense.  
 
The strengths of the current study are the 
inclusion of female participants and both 
habitual and caffeine naïve users. The 
inclusion of female participants is lacking in 
the current literature testing caffeine’s 
ergogenic effects (10, 17, 22, 24, 25). Few 
studies have evaluated the effects of 
caffeine supplementation on habitual and 
caffeine naïve users, (4, 15) and this is the 
first to date to evaluate the effects of 
habitual caffeine usage on a caffeine 
supplement in a sprint testing protocol.   
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This study also has limitations. One 
limitation of this study is the small 
heterogeneous sample size that included 
both collegiate athletes and recreationally 
active participants. The study by Collomp 
et al. (12) indicates that specific training 
may be needed to see a benefit from 
caffeine and the mixed sample may have 
produced mixed results. This is unlikely 
however because only 3 of the 18 
participants were collegiate athletes. 
Another limitation of this study was the 
absence of heart rate and blood lactate 
measurements. Based on previous findings 
it is likely that both blood lactate and heart 
rate increased with the caffeine 
supplement.  
 
Because this area is a relatively new area of 
study, more research is needed before 
definitive conclusions may be drawn about 
caffeine’s effect on sprint performance. 
More research is needed to test if habitual 
caffeine use decreases the effectiveness of 
the supplement before a definitive 
conclusion can be drawn. Research is also 
needed using RPE because the perception 
of effort is an important component to 
examine in light of potential increases in 
heart rate and blood lactate. Research 
including females is needed to determine if 
caffeine’s ergogenic effects are different for 
women and to determine the appropriate 
dosage time for women, because it may be 
different from that of men. This dosage 
timing is especially important for women 
using oral contraception, which has been 
shown to result in a longer time to 
metabolize caffeine (1, 23). While there was 
no documented sex difference in the 
current study, all but two of the female 
participants were taking oral contraceptives 
making it difficult to detect any difference 
due to oral contraceptive use.  
 
In conclusion, the results of this study 
indicate that caffeine supplementation 
using 6 mg·kg-1 body mass does improve 
sprint performance. Furthermore, the 
results indicate that habitual caffeine use 
did not cause decreased effectiveness of the 
caffeine supplement and the effect did not 
vary by sex. Overall, this study shows that 
caffeine does have the potential to improve 
sprint performance and may be beneficial 
to sports that incorporate sprinting. 
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